Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients: Insights from the STrategic Reperfusion Early After Myocardial infarction trial

Background Elderly patients with ST-segment elevation myocardial infarction (STEMI) have worse outcomes and a greater risk of intracranial bleeding than nonelderly patients. Baseline characteristics, clinical outcomes, and the relationship of the tenecteplase (TNK) dose reduction to the efficacy, sa...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American heart journal 2015-06, Vol.169 (6), p.890-898.e1
Hauptverfasser:	Armstrong, Paul W., MD, Zheng, Yinggan, MA, MEd, Westerhout, Cynthia M., PhD, Rosell-Ortiz, Fernado, MD, PhD, Sinnaeve, Peter, MD, PhD, Lambert, Yves, MD, Lopes, Renato D., MD, PhD, Bluhmki, Erich, MD, Danays, Thierry, MD, Van de Werf, Frans, MD, PhD
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Aged Aged, 80 and over Cardiovascular Clinical outcomes Electrocardiography Fibrinolytic Agents - administration & dosage Fibrinolytic Agents - adverse effects Heart attacks Humans Intracranial Hemorrhages - prevention & control Laboratories Medical imaging Middle Aged Mortality Myocardial Infarction - diagnostic imaging Myocardial Infarction - drug therapy Myocardial Infarction - physiopathology Radiography Tissue Plasminogen Activator - administration & dosage Tissue Plasminogen Activator - adverse effects Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!